MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617073879 A) filed by Systimmune, Inc. on June 15, 2026, for Anti-Dll3 Antibody And Method Of Making And Using Thereof.
Inventors include Dinkel, Kelcey, D.; Khalili, Jahan; and Zhu, Yi.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: A Delta-Like Ligand 3 (DLL3) binding peptide having a binding specificity to human DLL3, comprising an amino acid sequence having at least 98%, 95%, or 92% of sequence identity to SEQ ID NO: 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 37, 38, 39, 40, 41, 42, 43, 44, 45, or 46.
Disclaimer: Curated by HT Syndication....